Altimmune (ALT) Tax Rate (2012 - 2025)

Altimmune (ALT) posted quarterly Tax Rate of 31.03% for Q4 2025, down 1023.06% quarter-over-quarter from 3.36% in Q1 2025.

Altimmune (ALT) Tax Rate (2012 - 2025) Analysis & Trends

Altimmune (ALT) has reported Tax Rate for 11 consecutive years, with 31.03% the latest figure, recorded in Q4 2025.

In Q4 2025, Tax Rate changed N/A year-over-year to 31.03%; the TTM figure through Dec 2025 stood at 528.81% (changed N/A YoY), while the FY2025 annual figure was 528.81%, up 50781.0% from the prior year.
Tax Rate retreated to 31.03% in Q4 2025 per ALT's latest filing, from 3.36% in the prior quarter.
Across five years, Tax Rate topped out at 3.36% in Q1 2025 and bottomed at 31.03% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Altimmune	571.75 Mn	571.75 Mn	-	-

Download Data